Moreover, some 40 million uninsured people expected to receive coverage under healthcare reform are likely to need general, gynecologic, orthopedic and ENT surgery.
Medtronic has been seeking shelter from sagging earnings in its cardiac product segment by investing in surgical technologies, which account for less than 10 percent of the company’s sales.
Read the MedCity report on surgical products.
Related Articles on Surgical Products:
Single-Use Device Reprocessor Addresses 10 Misconceptions of the Industry
ASCs Should Take Advantage of Their Surgical Supply Distributors
IOM Calls for Overhaul of FDA Device Approval Process; MDMA Disagrees
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
